Pharmacopsychiatry 2009; 42(1): 36-37
DOI: 10.1055/s-0028-1085440
Letter

© Georg Thieme Verlag KG Stuttgart · New York

Use of Thiamine in the Treatment of Post-electroconvulsive Therapy Delirium

T. Ogihara 1 , M. Miyashita 1 , M. Kobayashi 1 , D. Sasayama 1 , S. Washizuka 1 , 2 , T. Hanihara 1 , 3 , N. Amano 1
  • 1Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Japan
  • 2Center for Health, Safety and Environmental Management, Shinshu University, Matsumoto, Japan
  • 3Department of Occupational Therapy, Shinshu University School of Health Science, Matsumoto, Japan
Further Information

Publication History

received 26.05.2008 revised 30.06.2008

accepted 09.07.2008

Publication Date:
19 January 2009 (online)

Electroconvulsive therapy (ECT) is a safe and effective treatment for refractory depression, mania, and psychosis [8] [10]. The common adverse effects of ECT are cognitive impairments such as retrograde amnesia and delirium. However, these conditions are usually transient and have a self-limiting course [3]. In elderly patients, the postictal state (post-ECT delirium) is occasionally prolonged and often accompanied by disorientation and agitation. Post-ECT delirium is troublesome and may necessitate discontinuation or reduction of the course of ECT in some patients. Various pharmacotherapies with benzodiazepines or antipsychosis drugs are prescribed to prevent post-ECT delirium [1]. However, the beneficial effects of these agents have been controversial. Linton et al. [6] reported major depression and post-ECT delirium in 3 elderly patients, and they were the first to describe the successful treatment of post-ECT delirium with thiamine. To date, no other report has been published in this field of literature. We report a case of severe post-ECT delirium that presented during treatment for delusional depression and the dramatic beneficial effects of thiamine in treating it.

References

  • 1 American Psychiatric Association .The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging, 2nd edition. Washington D.C.: American Psychiatric Press 2001
  • 2 Darbin O, Risso JJ, Carre E. et al . Metabolic changes in rat striatum following convulsive seizures.  Brain Res. 2005;  1050 124-129
  • 3 Devanand DP, Fitzsimons L, Prudic J. et al . Subjective side effects during electroconvulsive therapy.  Convulsive Ther. 1995;  11 232-240
  • 4 Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy.  J Neurol Neurosurg Psychiatry. 1986;  49 341-345
  • 5 Kassay G, Máthé V. The effect of thiamine on the electroshock-induced changes of the orientation reflex and of the nicotinic acid reaction in schizophrenics.  II Acta Neuroveg (Wien). 1964;  25 551-559
  • 6 Linton CR, Reynolds MTP, Warner NJ. Using thiamine to reduce post-ECT confusion.  Int J Geriatr Psychiatry. 2002;  17 189-192
  • 7 Máthé V, Kassay G. Effect of electroshock and thiamine on cerebral lactic acid and pyruvic acid content of the rat brain.  Acta Neuroveg (Wien). 1963;  25 325-331
  • 8 Neuhaus AH, Katchanov J, Opgen-Rhein C. et al . Electroconvulsive monotherapy in the treatment of acute confusion psychosis. A case report.  Pharmacopsychiatry. 2005;  38 330-332
  • 9 Pearce JMS. Wernicke-Korsakoff encephalopathy.  Eur Neurol. 2008;  59 101-104
  • 10 Pagnin D, Queiroz V de, Pini S. et al . Efficacy of ECT in depression: a meta-analytic review.  J ECT. 2004;  20 13-20
  • 11 Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations. Philadelphia: F.A. Davis Company 1971

Correspondence

T. OgiharaMD 

Department of Psychiatry

Shinshu University School of Medicine

Asahi-machi 3-1-1

Matsumoto 390-8621

Japan

Phone: +81/263/37 26 38

Email: togihara@shinshu-u.ac.jp

    >